Location History:
- Rodovre, DK (2018)
- Rødovre, DK (2019)
Company Filing History:
Years Active: 2018-2019
Title: Conni Lauritzen: Innovator in Peptidyl Nitril Compounds
Introduction
Conni Lauritzen is a notable inventor based in Rødovre, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of dipeptidyl peptidase I inhibitors. With a total of 2 patents, her work has the potential to impact various therapeutic applications.
Latest Patents
Lauritzen's latest patents include innovative compounds that serve as selective dipeptidyl peptidase I inhibitors. The first patent details compounds of Formula (I) and their use in pharmaceutical compositions. These compounds are designed to inhibit dipeptidyl peptidase I, which is crucial for various biological processes. The second patent reiterates similar findings, emphasizing the importance of these compounds in methods of treatment involving dipeptidyl peptidase I inhibition.
Career Highlights
Throughout her career, Conni Lauritzen has worked with several prominent companies in the biotechnology sector. Notably, she has been associated with Neuprozyme Therapeutics ApS and Prozymex A/S. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovations.
Collaborations
Lauritzen has collaborated with various professionals in her field, including her coworker John Pedersen. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Conni Lauritzen stands out as an influential inventor in the realm of pharmaceutical innovations. Her work on peptidyl nitril compounds showcases her commitment to advancing medical science. The impact of her patents may lead to significant advancements in treatment methodologies.